Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research
      • Clinical Trials
    • Contact Us
    • Investors
      Careers
636.449.1830

Important Safety Information

INDICATIONS AND USAGE

VAZCULEP® (phenylephrine hydrochloride) Injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

CONTRAINDICATIONS

None

WARNINGS AND PRECAUTIONS

  • Extravasation during intravenous administration may cause necrosis or sloughing of tissue
  • Severe bradycardia and decreased cardiac output
  • Allergic-type reactions: Sulfite
  • Concomitant use with oxytocic drugs: Pressor effect of sympathomimetic pressor amines is potentiated

ADVERSE REACTIONS

Most common adverse reactions during treatment: nausea, vomiting, and headache.

To report SUSPECTED ADVERSE REACTIONS, contact Avadel at 1-877-638-4579 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

1117 VAZ HCP ISI

View Prescribing Information

Products

  • Hospital
    • Bloxiverz ®
    • Vazculep ®
    • Akovaz ®

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
https://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com

© Avadel. All rights reserved.

Powered by Scorpion